Evidence-based Clinical Practice Guidelines for Prevention, Screening, and Treatment of Peripartum Depression
A Clinical Guidelines Group (CGG) was established in RiseupPPD with the overarching aim to develop and harmonize clinical recommendations for peripartum depression in Europe. The CGG has put in place guidelines based on high-quality research synthesis of current evidence of diagnosis and treatment of peripartum depression. Key stakeholders (including patients) are actively involved in the group, to ensure that the guidelines are understandable from the perspective of key stakeholders.
We are inviting all relevant stakeholders to provide their comments and thoughts on these European Guidelines before 31st of August 2023. All comments will be revised by the working group and assessed. If the comment is accepted by the group, it will result in a modification of the document. If not, the working group will formulate a reply. The details of the review procedure, the comments, modifications and replies, and the names of experts contributing to the review will be summarised in a review report which will be available on the Riseup-PPD website.
The draft document for stakeholder review can be found here.
Stakeholders may submit their comments and feedback in the following link: https://forms.gle/f7j7NBWpDRCzSjZs5